Related Experiment Video
Updated: Dec 1, 2025

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Cutaneous JAK Expression in Vitiligo
Amira A Abdel Motaleb1, Yasmin M Tawfik1, Mohamed A El-Mokhtar2
168797 Faculty of Medicine, Department of Dermatology, Venereology and Andrology, Assiut University, Egypt.
Background:
The Janus kinase-signal transducer and activator of transcription signaling pathway has been suggested as a promising therapeutic target in vitiligo. However, limited data is available on the cutaneous expression of JAK in vitiligo.
Aim:
This study is designed to analyze the cutaneous expression patterns of JAK1, 2, and 3 in vitiligo and investigate their relation to the disease clinical parameters.
Methods:
This case-control study recruited 24 patients having active vitiligo and 20 age, sex, and skin type-matched healthy volunteers. Skin biopsies were obtained from patients (lesional, perilesional and nonlesional) and controls for assessment of JAK1, 2, and 3 expression using RT-PCR.
Results:
JAK1 and JAK3 were overexpressed in patients' skin compared to control skin and showed a stepwise pattern of upregulation from control to nonlesional, perilesional and lesional skin. However, JAK3 showed much stronger expression. In contrast JAK2 expression showed no significant difference in any of lesional, perilesional or nonlesional skin compared to control skin. JAK1 and JAK3 expression levels showed no correlation with neither the disease activity nor severity.
Conclusion:
JAK1 and more prominently JAK3 are upregulated in vitiliginous skin and possibly contribute to the pathogenesis of the disease. Accordingly, selective JAK3/1 inhibition may provide a favorable therapeutic opportunity for vitiligo patients.This study is registered on the ClinicalTrials.gov Identifier: NCT03185312.
Insights
Janus kinase-1 (JAK1) and Janus kinase-3 (JAK3) are upregulated in vitiligo skin, suggesting they may play a role in the disease. Selective JAK3/1 inhibition could be a potential treatment for vitiligo.
Area of Science:
- Dermatology
- Immunology
- Molecular Biology
Background:
- The Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway is a potential therapeutic target for vitiligo.
- Limited data exists on the cutaneous expression of Janus kinases (JAKs) in vitiligo patients.
Purpose of the Study:
- To analyze the cutaneous expression patterns of JAK1, JAK2, and JAK3 in vitiligo.
- To investigate the relationship between JAK expression and clinical parameters of vitiligo.
Main Methods:
- A case-control study involving 24 active vitiligo patients and 20 healthy controls.
- Skin biopsies (lesional, perilesional, nonlesional) were analyzed for JAK1, JAK2, and JAK3 expression using RT-PCR.
Main Results:
- JAK1 and JAK3 were overexpressed in vitiligo skin compared to controls, with a stepwise increase from nonlesional to lesional skin.
- JAK3 expression was significantly higher than JAK1.
- JAK2 expression showed no significant difference between patients and controls.
Conclusions:
- JAK1 and particularly JAK3 are upregulated in vitiliginous skin, potentially contributing to disease pathogenesis.
- Targeted inhibition of JAK3/1 may offer a therapeutic strategy for vitiligo.
- Study registered on ClinicalTrials.gov (Identifier: NCT03185312).
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Papillary Dermis
The dermis might be considered the "core" of the integumentary system, as distinct from the epidermis and hypodermis. It contains blood and lymph vessels, nerves, and other structures, such as hair follicles and sweat glands. The dermis is made of two layers of connective tissue that comprise an interconnected mesh of elastin and collagenous fibers, produced by fibroblasts.
Papillary Layer
The papillary layer is made of loose, areolar connective tissue, which means the collagen...
Reticular Dermis
Reticular Layer
Underlying the papillary layer is the much thicker reticular layer, composed of dense, irregular connective...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
The JAK-STAT Signaling Pathway
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...

